Metabolism of C19- and C20-gibberellins by cell-free preparations from immature Phaseolus coccineus seed

Gibberellin biosynthesis pathways were investigated using isotopically-labelled C₁₉- and C₂₀-gibberellins and cell-free preparations from immature seed of Phaseous coccineus cv. Prizewinner. The initial steps in an early 13-hydroxylation pathway involved the conversion gibberellin A₁₂-aldehyde (GA₁₂-aldehyde) to GA₁₂ which was 13-hydroxylated to yield GA₅₃, Metabolism of GA₅₃ yielded GA₄₄. In contrast to other cell-free systems, GA₄₄ was not further converted, either as a δ-lactone or an open-lactone structure, to the C-20 aldehyde GA₁₉. GA₁₉ was, however, metabolised to GA₂₀, GA₅ and GA₁. GA₂₀ represented a branch point in the pathway as it was converted both to GA₁, which was an end product, and GA₅ which was further converted to GA₆. Like GA₁, GA₆ was also an end-product of the early 13-hydroxylation pathway.
A non-13-hydroxylation pathway involving GA₄, GA₁₅, GA₂₄ GA₃₇ and GA₃₆ also originated from GA₁₂. The terminal product of this pathway was the 3β-hydroxy C₁₉-gibberellin, GA₄.